Research Progress on Therapeutic Targeting of Cancer-Associated Fibroblasts to Tackle Treatment-Resistant NSCLC

Non-small cell lung cancer (NSCLC) accounts for most lung cancer cases and is the leading cause of cancer-related deaths worldwide. Treatment options for lung cancer are no longer limited to surgery, radiotherapy, and chemotherapy, as targeted therapy and immunotherapy offer a new hope for patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Chenxin, Qiu, Yusong, Zhang, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696940/
https://www.ncbi.nlm.nih.gov/pubmed/36422541
http://dx.doi.org/10.3390/ph15111411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696940/
https://www.ncbi.nlm.nih.gov/pubmed/36422541
http://dx.doi.org/10.3390/ph15111411

Ejemplares similares